Walgreens Boots Alliance is going private at $11.45/share plus up to $3 via a CVR, offering a potential $14.45 payout. See ...

As part of the national pharmacy chain’s effort to reduce its store count by 1,200 within three years, Walgreens will close ...

With a market cap of $10.1 billion, Walgreens Boots Alliance, Inc. (WBA) is a global healthcare, pharmacy, and retail company ...

Walgreens Boots Alliance Inc. (NASDAQ: WBA) is a leading global retail pharmacy and healthcare company. The stock is trading ...

Walgreens Boots Alliance should be a private company before the end of the year after jumping the potential hurdle of a shareholder vote on the proposed takeover.

Walgreens Boots Alliance reported weak Q1 2023 results - mostly due to $6.5B litigation associated with opioid settlements. Click here for our view of WBA now.

The drugstore industry is facing competition from the likes of Amazon.com Inc., as well as pressure on pharmacy-reimbursement rates for prescription drugs.

Walgreens Boots Alliance (NASDAQ:WBA) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-08. Here's a quick overview of what investors should know before the release. Analysts ...

Walgreens Boots Alliance is one of the largest retail pharmacy chains in the U.S., with over 8,500 locations. Nearly three quarters of Americans live within five miles of a Walgreens location.

Data source: Walgreens Boots Alliance. The worst might soon be over. Walgreens earned $2.88 per share in 2024 and guided for a decline in 2025 earnings to $1.40 on the low end.

Walgreens Boots Alliance has reported a $3.1 billion loss in the past year, but shares are trading for just 0.14 times sales, so there's an argument this could be a great value stock if the ...

After a decade of disappointing returns, now could be the time to buy. Household name and dividend growth stock Walgreens Boots Alliance (WBA 0.79%) hasn't been good to shareholders for some time now.